Company Filing History:
Years Active: 2021-2023
Title: Adam C Furman: Innovator in Haptic Therapeutics
Introduction
Adam C Furman is a notable inventor based in Bolton, MA (US), recognized for his contributions to the field of haptic technology and therapeutic systems. With a total of 3 patents, Furman has made significant strides in developing innovative solutions for managing tinnitus and enhancing sleep regulation.
Latest Patents
Furman's latest patents include a "Haptic tinnitus therapeutic system," which focuses on managing tinnitus through a combination of audio output and vibration applied to the user's body. This system utilizes a wearable device to actuate an electro-acoustic transducer and a contact element, creating a prescribed pattern that stimulates the nervous system while delivering sound to mitigate tinnitus symptoms. Another significant patent is "Biometric feedback as an adaptation trigger for active noise reduction, masking, and breathing entrainment." This invention provides methods and systems for closed-loop sleep protection and regulation by measuring biosignal parameters and ambient noise to determine a subject's sleep condition and take necessary actions to avoid sleep disruption.
Career Highlights
Furman is currently employed at Bose Corporation, a company renowned for its innovative audio products and technologies. His work at Bose has allowed him to explore the intersection of sound and therapeutic applications, leading to groundbreaking inventions that address real-world challenges.
Collaborations
Throughout his career, Furman has collaborated with esteemed colleagues, including Dale McElhone and Jeffrey M Ellenbogen. These partnerships have fostered a creative environment that encourages the development of cutting-edge technologies.
Conclusion
Adam C Furman stands out as a pioneering inventor in the realm of haptic therapeutics, with a focus on improving the quality of life for individuals suffering from tinnitus and sleep disturbances. His innovative patents and contributions to Bose Corporation highlight his commitment to advancing technology for therapeutic purposes.